Industry Focus Transcripts

The Federal Reserve is about to see some changes. Here are some of the most important things to know about the potential candidates, and what might change going forward.

Soon, investors will have the option to buy into Eminem’s music catalog -- here's how that’s possible, and what investors should know about alternate investments.

Here's what long-term investors need to know about how data center REITs work, and how the industry looks going forward.

The company will give viewers access to 10,000 live sporting events, 500 films, and over 7,000 television episodes. Traditional pay-TV subscriber numbers are on the decline, and CEO Bob Iger sees this streaming transition as his last major priority before retirement.

Unpacking Axovant Sciences big Alzheimer’s disease disappointment, plus Pfizer accuses Johnson & Johnson of unfairly increasing healthcare costs.

Alarm.com, Impinj, and Paycom aren't household names yet, but they are transforming markets worth billions of dollars, and that could make them savvy investments.

Auto sales have declined 2% this year after sales broke records in 2016, leading to speculation about whether the U.S. has reached peak auto. However, one area of the market -- SUVs, light trucks, and crossovers -- continues to demonstrate growth.

We rip open the mailbag and answer questions regarding clinical trials, drug patents, and retail pharmacy profits.

The Industry Focus team looks at the growing popularity of online education.

Don't get sick before you see this informative quick guide.

Edge-to-edge display? Check. Wireless charging? Check. Facial recognition components? Check. The iPhone X is gorgeous, but what does its release timing mean for Apple’s financials over the next few quarters? We dig into that and Apple’s other upcoming products.

It’s not always an easy decision, and in most cases you should do some planning first, but there are times when you’re doing the right thing by quitting your job.

After years of being dubbed “death traps” for investors, the airlines industry is having something of a renaissance. We discuss which of the big four U.S. national carriers is the better buy for investors today.

A new study concludes it costs $757 million to develop a new cancer drug, but is that the only reason why drugmakers charge sky-high drug prices or are other reasons to blame, too?

In a strange twist, the newest retail store from Nordstrom will carry no inventory. Instead, the company hopes a unique menu of services will provide a rich enough experience to connect with shoppers -- a trend that is growing quickly in the brick-and-mortar world.

The streaming service is planning to go public soon, and we have our hands on the filing with the SEC. We run through the company's books, talk about the streaming space, and look at the company's long-term prospects.

Energy Secretary Rick Perry announced that the Department of Energy is releasing 500,000 barrels of oil from the Strategic Petroleum Reserve. We discuss the impact and importance of the move.

Amazon has already begun to weaponize its Whole Foods locations -- we look at how competing retailers are feeling the pressure.

Big-cap biopharma could come knocking if Juno Therapeutics’ next-generation CAR-T is safer than its competitors, and Medtronic's already investing billions in Mazor Robotics, a maker of surgical robots.

Today, we dust off our college accounting books to talk about the difference between capitalizing and expensing a purchase, what deferred revenue is, and why operating leverage is a beautiful thing.